NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers
Clinical trial NCT04808531 · UNKNOWN
Trial details
- NCT number
- NCT04808531
- Sponsor
- Medlab Clinical
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-02-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.